<?xml version='1.0' encoding='utf-8'?>
<document id="23041466"><sentence text="How many potential drug-drug interactions cause adverse drug reactions in hospitalized patients?" /><sentence text="Potential drug-drug interactions (DDIs) are frequent in drug prescription but clinically significant are the ones which can result in changes of therapeutic effect of one of the two drugs or in adverse drug reactions (ADRs)" /><sentence text=" The aim of this study was to assess the potential DDIs as well as the DDIs which cause adverse drug reactions (ADRs) in an internal medicine department hospitalized patients" /><sentence text="" /><sentence text="The prospective study included all patients admitted between November 2010 and January 2011 in an internal medicine ward" /><sentence text=" Information on patients' demographics and their medication use history was obtained from each patient by interview" /><sentence text=" In addition, medical history, medication use during hospitalization, and relevant laboratory and clinical data were obtained from medical records" /><sentence text=" Potential DDIs were identified using the Thomson Micromedex program" /><sentence text=" Each patient was monitored during the hospitalization period in order to detect the ADRs resulting from DDI's if present" /><sentence text="" /><sentence text="Three hundred and five patients were enrolled in this study during 3 months" /><sentence text=" Of 1279 potential DDIs, Fourteen led to 13 ADRs out of which 8 were serious and caused hospital admission or prolongation of hospitalization" /><sentence text=" There was a statistically significant association between ADRs related to DDIs and the presence of ATC (Anatomical Therapeutic Chemical) C medication during hospitalization and the length of hospital stay, in the multivariate analysis" /><sentence text="" /><sentence text="Awareness of the most commonly occurring DDIs should be raised by the utilization of drug-drug interaction guides in the Romanian clinical practice which can help prescribers and pharmacists prevent DDI related ADRs" /><sentence text="" /></document>